| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.33B | 29.18B | 27.74B | 29.94B | 19.78B |
| Gross Profit | 128.03M | 254.97M | 154.70M | 155.59M | 292.68M |
| EBITDA | -16.67M | 250.90M | 888.04M | -388.06M | 513.31M |
| Net Income | -758.61M | 54.13M | 217.59M | -199.51M | 353.60M |
Balance Sheet | |||||
| Total Assets | 2.76B | 2.80B | 3.68B | 4.52B | 4.51B |
| Cash, Cash Equivalents and Short-Term Investments | 63.72M | 278.68M | 226.19M | 436.62M | 394.13M |
| Total Debt | 747.85M | 670.76M | 945.60M | 1.25B | 955.26M |
| Total Liabilities | 2.18B | 1.50B | 2.34B | 4.05B | 3.34B |
| Stockholders Equity | 555.57M | 1.25B | 1.29B | 772.96M | 1.04B |
Cash Flow | |||||
| Free Cash Flow | -269.79M | 310.81M | 49.34M | -377.34M | -9.49M |
| Operating Cash Flow | -261.13M | 375.64M | 406.82M | 89.14M | 223.93M |
| Investing Cash Flow | -8.66M | -65.22M | -357.48M | -466.49M | -233.42M |
| Financing Cash Flow | 44.14M | -248.76M | 55.38M | 141.32M | -45.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.02T | 7.09 | 15.25% | 6.76% | -3.90% | -11.54% | |
71 Outperform | HK$1.85T | 10.38 | 10.04% | 6.32% | -1.41% | -2.26% | |
67 Neutral | HK$48.19B | 13.49 | 8.25% | 3.59% | 4.22% | 22.46% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
58 Neutral | HK$9.35B | 8.28 | 8.60% | 20.93% | 9.52% | -28.22% | |
55 Neutral | HK$603.11B | 14.82 | 4.45% | 5.52% | -7.22% | -15.49% | |
44 Neutral | HK$308.03M | -0.41 | -82.00% | ― | -40.63% | -1501.63% |